PP01.31 Real-World Treatment Outcomes of Amivantamab in Pre-Approval Access (PAA) Participants with Advanced Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Mutations (ex20ins)

Autor: Sabari, J., Kim, T.M., Spira, A., Lee, S.H., Chang, G.C., Shih, J.-Y., Hochmair, M.J., Schioppa, C.A., Schioppa, C.A., Panaccione, A., Rose, J.B., Chioda, M., Mahadevia, P., Cho, B.C.
Zdroj: Journal of Thoracic Oncology; March 2023, Vol. 18 Issue: 3, Number 3 Supplement 1 pe23-e23, 1p
Databáze: Supplemental Index